Earlier studies found positive associations of adiponectin with progression and disease severity in MS, as well as with inflammation and progression in rheumatoid arthritis, chronic kidney disease and inflammatory bowel disease [31, 33, 34]. Here, ADIPOQ is linked to myeloid sarcoma.